Moini A, Arabipoor A, Ashrafinia N
Department of Endocrinology and Female Infertility at Reproductive Biomedicine Research Center Royan Institute for Reproductive Biomedicine ACECR, Tehran, Iran -
Minerva Med. 2014 Aug;105(4):295-301. Epub 2014 Jun 10.
Objective of the study was to evaluate the risk factors that influence the recurrence of endometrioma after laparoscopic excision.
A cross-sectional study was performed at Arash University Hospital between 2009 and 2011 on patients who had a minimum of one year of postoperative follow-up after undergoing a laparoscopic excision of an ovarian endometrioma. The patients had any prior surgery for ovarian endometriomas was excluded. Recurrence was defined as the presence of endometrioma more than 2 cm in size, detected by ultrasonography within 1 year of surgery. The variables including age at surgery, presence of infertility, uterine myoma, previous medical treatment of endometriosis, the size of the largest cyst at laparoscopy, unilateral or bilateral involvement, serum CA125 level, revised American Society for Reproductive Medicine (ASRM) score and stage, postoperative medical treatment and postoperative treatment were evaluated to assess their independent effects on the recurrence using logistic regression analysis.
A total of 158 patients were admitted to the Surgery Unit for endometriomas cystectomy during the study period. After the initial assessment, 130 patients were eligible for the study. The overall rate of recurrence was 11.5% (15/130). Significant factors that were independently associated with higher recurrence were the size of the largest cyst (odds ratio [OR] =4, 95% confidence interval [95% CI] =1.6-10.4, P=0.002), a high rASRM score (OR=1.2, 95% CI=1-1.4, P=0.04) and woman age at surgery (OR=0.6, 95% CI=0.4-0.9, P=0.01).
A high score of rASRM, large cyst size and young age at surgery were three significant factors that were associated with higher recurrence of endometriomas.
本研究的目的是评估影响腹腔镜切除术后子宫内膜瘤复发的危险因素。
2009年至2011年在阿拉什大学医院进行了一项横断面研究,研究对象为接受卵巢子宫内膜瘤腹腔镜切除术后至少有一年术后随访的患者。排除曾接受过卵巢子宫内膜瘤手术的患者。复发定义为术后1年内超声检查发现大小超过2 cm的子宫内膜瘤。评估手术时年龄、不孕情况、子宫肌瘤、既往子宫内膜异位症治疗情况、腹腔镜检查时最大囊肿大小、单侧或双侧受累情况、血清CA125水平、修订后的美国生殖医学学会(ASRM)评分和分期、术后药物治疗和术后治疗等变量,采用逻辑回归分析评估它们对复发的独立影响。
在研究期间,共有158例患者因子宫内膜瘤囊肿切除术入住外科病房。经过初步评估,130例患者符合研究条件。总体复发率为11.5%(15/130)。与较高复发率独立相关的显著因素是最大囊肿大小(比值比[OR]=4,95%置信区间[95%CI]=1.6-10.4,P=0.002)、高rASRM评分(OR=1.2,95%CI=1-1.4,P=0.04)和手术时女性年龄(OR=0.6,95%CI=0.4-0.9,P=0.01)。
高rASRM评分、囊肿大尺寸和手术时年龄小是与子宫内膜瘤较高复发率相关的三个显著因素。